We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Unresectable Non-Small Cell Lung Cancer Chemotherapy with High-Dose Cisplatin and Etoposide.
- Authors
Scagliotti, Giorgio V.; Lodico, Donatella; Gozzelino, Felice; Bardessono, Franco; Albera, Carlo; Gatti, Emiliano; Pescetti, Giovanni
- Abstract
69 patients with unresectable non-small cell lung cancer, previously untreated, received cisplatin 100 mg/m2 on day 1 and etoposide 120 mg/m2 on days 4, 6, 8 at 4-week intervals. 66 patients were evaluable for tumor response and toxicity. Overall objective response was 25.7% (3 complete responses and 14 partial responses). Response rate in limited disease was 41% and in patients with performance score 0 it was 40%. Squamous cell carcinoma and adenocarcinoma responded in 31 and 24% of evaluable patients. Complete response was associated with a long duration of remission. Median survival time of responding patients was significantly superior to the median of nonresponding patients (p <0.001) but compared to stable disease no statistical significance was demonstrable (p >0.05). Hematological and renal toxicity of proposed regimen was generally mild. Nausea and vomiting were the most noxious side effects. Copyright © 1985 S. Karger AG, Basel
- Publication
Oncology, 1985, Vol 42, Issue 4, p224
- ISSN
0030-2414
- Publication type
Article
- DOI
10.1159/000226035